CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Artificial Organs
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Artificial Heart
4.2.5.1. Market Size and Forecast
4.2.6. Artificial Kidney
4.2.6.1. Market Size and Forecast
4.2.7. Artificial Lungs
4.2.7.1. Market Size and Forecast
4.2.8. Others
4.2.8.1. Market Size and Forecast
4.3. Medical Bionics
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Orthopedic Bionics
4.3.5.1. Market Size and Forecast
4.3.6. Others
4.3.6.1. Market Size and Forecast
CHAPTER 5: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Mechanical
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Electronic
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By Technology
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Artificial Vital Organs and Medical Bionics Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By Technology
6.2.6. Canada Artificial Vital Organs and Medical Bionics Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By Technology
6.2.7. Mexico Artificial Vital Organs and Medical Bionics Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By Technology
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By Technology
6.3.4. Market Size and Forecast, By Country
6.3.5. France Artificial Vital Organs and Medical Bionics Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By Technology
6.3.6. Germany Artificial Vital Organs and Medical Bionics Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By Technology
6.3.7. Italy Artificial Vital Organs and Medical Bionics Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By Technology
6.3.8. Spain Artificial Vital Organs and Medical Bionics Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By Technology
6.3.9. UK Artificial Vital Organs and Medical Bionics Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By Technology
6.3.10. Rest Of Europe Artificial Vital Organs and Medical Bionics Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By Technology
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By Technology
6.4.4. Market Size and Forecast, By Country
6.4.5. China Artificial Vital Organs and Medical Bionics Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By Technology
6.4.6. Japan Artificial Vital Organs and Medical Bionics Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By Technology
6.4.7. India Artificial Vital Organs and Medical Bionics Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By Technology
6.4.8. South Korea Artificial Vital Organs and Medical Bionics Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By Technology
6.4.9. Australia Artificial Vital Organs and Medical Bionics Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By Technology
6.4.10. Rest of Asia-Pacific Artificial Vital Organs and Medical Bionics Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By Technology
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By Technology
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Artificial Vital Organs and Medical Bionics Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By Technology
6.5.6. South Africa Artificial Vital Organs and Medical Bionics Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By Technology
6.5.7. Saudi Arabia Artificial Vital Organs and Medical Bionics Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By Technology
6.5.8. Rest of LAMEA Artificial Vital Organs and Medical Bionics Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By Technology
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. SynCardia Systems LLC
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Abbott Laboratories, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Cochlear Limited
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Boston Scientific Corporation
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Johnson And Johnson
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Edwards Lifesciences Corporation
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Zimmer Biomet Holding Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Berlin Heart GmbH
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Jarvik Heart, Inc.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Medtronic Plc.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL ORGANS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 5. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MECHANICAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ELECTRONIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 9. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 11. U.S. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 12. U.S. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 13. CANADA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 14. CANADA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 15. MEXICO ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 16. MEXICO ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 17. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 18. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 20. FRANCE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 21. FRANCE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 24. ITALY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 25. ITALY ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 26. SPAIN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 27. SPAIN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 28. UK ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 29. UK ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 30. REST OF EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 31. REST OF EUROPE ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 32. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 33. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 35. CHINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 36. CHINA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 39. INDIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 40. INDIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 41. SOUTH KOREA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 42. SOUTH KOREA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 43. AUSTRALIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 44. AUSTRALIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 45. REST OF ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 46. REST OF ASIA-PACIFIC ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 47. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 48. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 50. BRAZIL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 51. BRAZIL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 52. SOUTH AFRICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 53. SOUTH AFRICA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 56. REST OF LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 57. REST OF LAMEA ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 58. SYNCARDIA SYSTEMS LLC: KEY EXECUTIVES
TABLE 59. SYNCARDIA SYSTEMS LLC: COMPANY SNAPSHOT
TABLE 60. SYNCARDIA SYSTEMS LLC: OPERATING SEGMENTS
TABLE 61. SYNCARDIA SYSTEMS LLC: PRODUCT PORTFOLIO
TABLE 62. SYNCARDIA SYSTEMS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 63. ABBOTT LABORATORIES, INC.: KEY EXECUTIVES
TABLE 64. ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 65. ABBOTT LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 66. ABBOTT LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 67. ABBOTT LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. COCHLEAR LIMITED: KEY EXECUTIVES
TABLE 69. COCHLEAR LIMITED: COMPANY SNAPSHOT
TABLE 70. COCHLEAR LIMITED: OPERATING SEGMENTS
TABLE 71. COCHLEAR LIMITED: PRODUCT PORTFOLIO
TABLE 72. COCHLEAR LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 74. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 75. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 76. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 77. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 78. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 79. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 80. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 81. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 82. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 83. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 84. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 85. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 86. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 87. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 88. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 89. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 90. ZIMMER BIOMET HOLDING INC.: OPERATING SEGMENTS
TABLE 91. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 92. ZIMMER BIOMET HOLDING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 94. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 95. BERLIN HEART GMBH: OPERATING SEGMENTS
TABLE 96. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 97. BERLIN HEART GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 99. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 100. JARVIK HEART, INC.: OPERATING SEGMENTS
TABLE 101. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 102. JARVIK HEART, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. MEDTRONIC PLC.: KEY EXECUTIVES
TABLE 104. MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 105. MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 106. MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 107. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
FIGURE 10. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION, BY TYPE
FIGURE 11. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ARTIFICIAL ORGANS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MEDICAL BIONICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 14. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR MECHANICAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET FOR ELECTRONIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 17. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 19. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 20. COMPETITIVE DASHBOARD
FIGURE 21. COMPETITIVE HEATMAP: ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET
FIGURE 22. TOP PLAYER POSITIONING, 2023
FIGURE 23. SYNCARDIA SYSTEMS LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 24. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 25. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 26. ABBOTT LABORATORIES, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 27. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 28. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 29. COCHLEAR LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. COCHLEAR LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. COCHLEAR LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. ZIMMER BIOMET HOLDING INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. BERLIN HEART GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. BERLIN HEART GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. BERLIN HEART GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. JARVIK HEART, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. JARVIK HEART, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. JARVIK HEART, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. MEDTRONIC PLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2023 (%)